Brief: Cytotools says Indian regulatory authorities recommend approval of Dermapro
Oct 30 (Reuters) - Cytotools AG T5OG.DE :
* Indian regulatory authorities recommend approval of
Dermapro, data of the phase III clinical trial to be submitted
in November
Source text for Eikon: ID:nEQ9t2H3la
Further company coverage: T5OG.DE
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 698 3920;))
Recent news on bioXXmed AG
See all newsBrief: CytoTools Announces Completion Of Capital Increase
Brief: CytoTools - Disputes Between CytoTools, DermaTools, Shareholders Ended
Brief: CytoTools Announces Retirement Of Two Members Of Management Board
Brief: CytoTools Sees Complete Change Of Management Board And Supervisory Board Possible
Lordstown Motors says hedge fund may buy up to $400 mln of its stock (updated)